Skip to main content
. Author manuscript; available in PMC: 2020 Sep 2.
Published in final edited form as: Oncogene. 2020 Mar 2;39(17):3413–3426. doi: 10.1038/s41388-020-1234-3

Figure 4.

Figure 4.

Genetically engineered RCC mouse models.

Strengths and limitations of relevant RCC GEM models, and the pathology recapitulated by each are outlined.